Document is current
Any future updates will be listed below
-
Authors
Khoo, James
Zammit, Gary
Mayleben, David
Fietze, Ingo
Pain, Scott
Gimona, Alberto
Kinter, Dalma Seboek
Dauvilliers, Yves
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03545191 at ClinicalTrials.govnct03575104 at ClinicalTrials.govDocuments that mention this clinical trial
Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem
https://doi.org/10.1007/s40263-023-01020-9
What place for daridorexant?
https://doi.org/10.1136/dtb.2023.000037
P4 Daridorexant improves total sleep time (TST) in insomnia patients without altering the proportion of sleep stages
https://doi.org/10.1136/bmjresp-2023-bssconf.15
Meaningful Within-Patient Change on the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ): Analysis of Phase III Clinical Trial Data of Daridorexant
https://doi.org/10.1007/s40290-023-00484-w
Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial
https://doi.org/10.1007/s40266-022-00977-4
Documents that mention this clinical trial
What place for daridorexant?
https://doi.org/10.1136/dtb.2023.000037
P4 Daridorexant improves total sleep time (TST) in insomnia patients without altering the proportion of sleep stages
https://doi.org/10.1136/bmjresp-2023-bssconf.15
- License Information
